Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
-
681
-
682
-
683
-
684
-
685
-
686
-
687
-
688
-
689
-
690
-
691
-
692
The difference of drug sensitivity between high and low-GSRS subjects in the TCGA-KIRC cohort.
Published 2025Subjects: -
693
-
694
-
695
-
696
-
697
-
698
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
699
-
700